Hépatite

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Hépatite

22. Décembre 2024

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 4206


	Articles 1 - 20 / 84110

	Hepatitis B Care and Treatment in Zanzibar, Tanzania: A Demonstration Project Following 2015 WHO Treatment Guidelines, 2017-2021. J Viral Hepat Said SS, Shadaker S, McMahon BJ, Armstrong PA, Beckett GA, Kamili S, Harris AM. PMID: 39707980 [PubMed - indexed for MEDLINE]
	Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection. Harm Reduct J Steffen G, Krings A, Guttmann S, Lübke N, Meyer-Schlinkmann K, Tiemann C, Timm J, Walker A, Zimmermann R, DRUCK 2.0-study group. PMID: 39707505 [PubMed - indexed for MEDLINE]
	Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design. Virol J Wu M, Mai J, Zhang H, Zhang G, Mao J, Tang Y, Yan W, Wu W, Hou J, Liang X, Liu Z, Ding Y, Niu J. PMID: 39707469 [PubMed - indexed for MEDLINE]
	Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study. Harm Reduct J Aung P, Hellard M, Dietze P, Petrovic B, Higgs P, Stoové M. PMID: 39707328 [PubMed - indexed for MEDLINE]
	One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing. J Med Virol Fan Z, Xu L, Cao Y, Liu T, Tian Y, Pan Z, Mo Y, Wang X, Zhu X, Gao Y, Zhang X, Pan CQ, Wang L, Ren F. PMID: 39704190 [PubMed - indexed for MEDLINE]
	Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study. Cancer Med Hu B, Yang Y, Yao J, Lin G, He Q, Bo Z, Zhang Z, Li A, Wang Y, Chen G, Shan Y. PMID: 39702929 [PubMed - indexed for MEDLINE]
	Global, regional, and national temporal trends in incidence and mortality for liver cancer due to hepatitis B, 1990-2021: a decomposition and age-period-cohort analysis for the Global Burden of Disease Study 2021. Hepatol Int Li J, Bai H, Gao Z, Gao L, Wang W, Li Y, Lian J, Yao T, Wang K, Hao R, Wang S, Feng Y. PMID: 39702656 [PubMed - as supplied by publisher]
	Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon Î±-2b for 48 weeks. Hepatol Int Tan Z, Kong N, Zhang Q, Gao X, Shang J, Geng J, You R, Wang T, Guo Y, Wu X, Zhang W, Qu L, Zhang F. PMID: 39702655 [PubMed - as supplied by publisher]
	HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study. BMC Infect Dis He Y, Ye S, Zhang W, Lu R, Lin J, Zhou C, Wu G. PMID: 39702202 [PubMed - indexed for MEDLINE]
	Taraxasterol extracted from Ixeridium gramineum (Fisch.) Tzvel. attenuated D-GalN/LPS-Induced Fulminant Hepatitis by modulating the JAK/STAT and TNF signalling pathways. J Ethnopharmacol Wang G, Yin Y, Lv R, Ling X, Cao H, Liu H, Wu J, Gao Y, Zhang K, Wang Y. PMID: 39701218 [PubMed - as supplied by publisher]
	Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons. Lancet Public Health Kronfli N, Bromberg DJ, Wolff H, Montanari L, Vasyliev S, Altice FL. PMID: 39701113 [PubMed - as supplied by publisher]
	Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study. Hepatol Int Wu JW, Chen WT, Huang CG, Chen YC, Hsu CW, Chien RN, Chang ML. PMID: 39699792 [PubMed - as supplied by publisher]
	Clinical characteristics of coronavirus disease 2019 patients with hepatitis B virus super-infection. Rev Inst Med Trop Sao Paulo Yu S, Song C. PMID: 39699512 [PubMed - indexed for MEDLINE]
	Trends and projections of Hepatitis A incidence in eastern China from 2007 to 2021: an age-period-cohort analysis. Front Public Health Peng H, Wang Y, Wei S, Kang W, Zhang X, Cheng X, Bao C. PMID: 39697280 [PubMed - indexed for MEDLINE]
	Safety and efficacy of 48-week pegylated interferon-Î±-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study. Front Med (Lausanne) Wang Z, Wang X, Zhou L, Shi S, Hua Y, Feng Y. PMID: 39697201 [PubMed]
	Overview of chronic hepatitis B management. Nurse Pract Jun A, Bau S, Kim JS, Phillips SJ. PMID: 39696735 [PubMed - indexed for MEDLINE]
	Evaluating hepatitis B screening, prevalence, vaccination coverage, and linkage to care in Abuja, Nigeria: insights from a cross-sectional study. BMC Public Health Akabuike OM, Aworh MK, Uzoebo NL, Erwat J, Agukwe O, Ngong K, Dangana A, Enwerem K, Abdullahi IN. PMID: 39696217 [PubMed - indexed for MEDLINE]
	Seroprevalence of hepatitis B among the general population in Shandong Province, Eastern China, an update 30 years after the implementation of the neonatal vaccination program. BMC Infect Dis Yan B, Zhang X, Lv J, Feng Y, Meng X, Lin X, Zhang Y, Wang S, Ji F, Chen M, Yuan X, Tao Z, Zhang L. PMID: 39695996 [PubMed - indexed for MEDLINE]
	Bacterial infection adversely increases the risk of decompensation in patients with hepatitis B virus-related compensated cirrhosis: a retrospective study. BMC Infect Dis Li Y, Niu B, Liu J, Zhou H, Chen Z, Zhou Y, Wei Q, Jiao X, Mi Y, Li P. PMID: 39695967 [PubMed - indexed for MEDLINE]
	Effect of SARS-CoV-2 infection on liver function in patients with hepatitis B. BMC Infect Dis Sun T, Chi H, Wang J, Zheng Y, Zhu H, Zhao J, Zhou K, Chen M, Wang D, Tung TH, Xu J, Shen B. PMID: 39695950 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 84110

Page 1 de 4206



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité